Search results
What Democratic voters say they want, and what the president has offered so far
AOL· 4 hours agoWhen it comes to President Joe Biden's chances of returning to the White House next year, one issue...
First trial over Zantac cancer claims set to begin in Chicago
Reuters via AOL· 6 days ago(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 7 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 6 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Francisco Chronicle· 6 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Psychedelic Tx: What Meaningful Informed Consent Looks Like
Medscape· 7 days agoA psychedelic renaissance is underway in psychiatric medicine, with a growing number of studies...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 6 days agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC· 3 days agoAmgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data on its...
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Bloomberg· 4 days agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 6 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...